Mon, Jan 26, 2015, 4:18 AM EST - U.S. Markets open in 5 hrs 12 mins


% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • larrystone13 larrystone13 Nov 21, 2012 11:00 AM Flag

    Seeking " SRPT Will Easily Approach $75 " linked

    Wednesday's Bio-Pharma Catalyst Trades And Watch List
    November 21, 2012
    I think it's a good bet Sarepta gets the early approval, which would likely cause the stock price to explode from its current price level of $27 a share -- I can easily see a stock price approaching $75 or higher here.
    DMD is a very rare disease that affects mainly children -- a potential cure for any form of MD would be on par with Jonas Salk's discovery of the Polio vaccine in my strong opinion.
    Between the 5 analysts that cover the stock, the mean price target is a whopping $44.20.

12.18-0.05(-0.37%)Jan 23 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.